arBtrage CAPITALIZING MARKETS checking… Sign in

Milestone Pharmaceuticals Inc.

MIST Health Care Biotechnology: Pharmaceutical Preparations
$1.23
▼ -4.7% Today
as of Jun 7, 07:21 ET
Last 30 days -33.51% Apr 28 → Jun 05
$1.17 $1.39 $1.60 $1.81 $2.03 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.28
High
$1.28
Low
$1.21
Volume
$2M
Avg Vol
$3M
Mkt Cap
$179M
P/E (TTM)
Beta
52w High
$3.06
52w Low
$1.00
Div Yield
Shares Out
$118M

Overview

52-week range
$1.00
$3.06
11% of range
Avg surprise (last 2)
-314.9%
Avg reaction (last 2)
-5.6%
0% positive
Latest IV / EM
352%
EM ±48.8% · $1 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.37$-0.29$-0.20$-0.11$-0.03 Actual $-0.37Actual $-0.35Actual $-0.21Actual $-0.14Actual $-0.14Actual $-0.31Est $-0.19Actual $-0.20Actual $-0.12Actual $-0.20Est $-0.03 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-26M$-19M$-13M$-6M$249,900 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.20 $-0.03 -566.7% +35.5% -9.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.12 financials
Mon Jun 30, 2025Jun 2025 $-0.20 financials
Wed May 14, 2025Mar/2025 $-0.31 $-0.19 -63.2% -1.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 financials
Sun Jun 30, 2024Jun 2024 $-0.14 financials
Sun Mar 31, 2024Mar 2024 $-0.21 financials
Sat Sep 30, 2023Sep 2023 $-0.35 financials
Fri Jun 30, 2023Jun 2023 $-0.37 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$238,000
Cost of revenue$14,000$0
Gross profit
Operating income$-24M$-12M$-13M$-21M$-10M$-10M
Net income$-26M$-12M$-13M$-21M$-9M$-9M
EPS (diluted)$-0.20$-0.12$-0.20$-0.31$-0.14$-0.14

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$71M$73M$47M$42M$45M$25M$13M$13M
Inventory$2M$648,000
Total current assets$192M$112M$87M$46M$60M$74M$81M$87M
Total assets$194M$114M$88M$47M$62M$75M$83M$89M
Long-term debt$58M$57M$56M$55M$54M$53M$52M$52M
Total liabilities$158M$72M$67M$65M$68M$62M$59M$57M
Total equity$36M$42M$21M$-18M$-6M$13M$24M$32M

Implied volatility — last 90 days

347%349%352%354%357% Jun 07 — IV 352% · EM ±48.8%

Sector peers